Tmunity:Kite to Acquire Tmunity Therapeutics to Pursue Next ...
Kite to Acquire Tmunity Therapeutics to Pursue Next ...
2022年12月20日—TheacquisitionofTmunitycomplementsKite'sexistingin-housecelltherapyresearchcapabilitiesbyaddingadditionalpipelineassets, ...。其他文章還包含有:「Gilead旗下Kite併購CAR」、「KiteCompletesAcquisitionofTmunity」、「Kite收购CAR」、「TmunityRaises$75MillioninSeriesBFinancingtoAdvance...」、「TmunityTherapeutics」、「TmunityTherapeuticsIncorporated」、「Tmunity療法公司」
查看更多 離開網站Gilead旗下Kite併購CAR
https://news.gbimonthly.com
Carl June在2015 年領銜彙聚6位科學家共同創立Tmunity,致力於突破實體瘤細胞治療方法,並顯著降低T細胞生產的成本,後續也獲多家知名創投青睞,如矽谷 ...
Kite Completes Acquisition of Tmunity
https://www.gilead.com
The acquisition of Tmunity complements Kite's existing in-house cell therapy research capabilities by adding additional pipeline assets, ...
Kite收购CAR
http://www.phirda.com
Tmunity是一家处于临床阶段的生物医药公司,专注于开发下一代T细胞免疫疗法。该公司的核心技术和创始人团队源于美国宾夕法尼亚大学(简称“宾大”),其创始 ...
Tmunity Raises $75 Million in Series B Financing to Advance ...
https://www.acsbrightedge.org
Tmunity is a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell ...
Tmunity Therapeutics
https://www.biospace.com
沒有這個頁面的資訊。
Tmunity Therapeutics Incorporated
https://tw.linkedin.com
Tmunity is now part of Kite, a Gilead Company. Kite's singular focus is cell therapy to treat and potentially cure cancer.
Tmunity療法公司
https://news.gbimonthly.com
以美國科學院院士、賓州大學終身教授CarlJune作為核心科學創始人的細胞療法新銳Tmunity,在創立之初,就擁有無與倫比的科學創始團隊。2018年1月,Tmunity宣佈獲得近億美元 ...